4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001193125-26-122268
Chief Financial Officer sold 3,708 shares at $46.78 ($173,460)
- Chief Financial Officer acquired 6,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Prasad Raju · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-20 | Exercise or conversion : show line 1 in the form | +6,250 | 19,273 | D | ||
| 2026-03-23 | Sale : show line 2 in the form | −3,708 | $46.78 | $173,460 | 15,565 | D |
| Open-market sales · 3,708 sh · avg $46.78 · $173,460 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-20 | Grant or award : show line 3 in the form Stock Option (Right to Buy) | +38,499 | 38,499 | D |
| 2026-03-20 | Grant or award : show line 4 in the form Restricted Stock Units | +27,500 | 27,500 | D |
| 2026-03-20 | Exercise or conversion : show line 5 in the form Restricted Stock Units | −6,250 | 12,500 | D |
Loading xslF345X06/ownership.xml…